Few corners of the market are as tempting as biotech catalyst trading. A small company has a single drug awaiting… Read more »
Few corners of the market are as tempting as biotech catalyst trading. A small company has a single drug awaiting… Read more »
Biotech stocks can offer some of the most spectacular returns in the stock market, with relatively small companies sometimes seeing… Read more »
The bullish engulfing candle is probably the most widely taught reversal pattern in technical analysis. A small down candle is… Read more »
A finished backtest isn’t a green light to trade live — it’s a reason to forward test first. Here’s how to set one up correctly, how long to run it, and the checklist to clear before risking real money.
Given enough flexibility, you can draw a curve through almost any set of points — including pure noise. Here’s what that has to do with a trading strategy that looks perfect in backtesting, and a simple visual check you can run yourself.
A backtest can look flawless and still be worthless. Here’s how overfitting happens, why it’s so easy to do by accident, and the specific tests that catch it before real money is on the line.
Artificial intelligence is increasingly being used by traders and investors to research companies, analyse financial results and identify potential opportunities… Read more »
Cathie Wood makes some of the boldest price targets in investing. We looked at what she’s actually predicted over the years, what happened to those calls, and what she’s forecasting now for Tesla, Bitcoin and beyond.
Every strategy eventually hits a rough patch, and it’s rarely obvious whether that’s genuine decay or a normal losing streak playing out. Here’s how to actually tell the difference before you abandon or keep trading a struggling system.
Every risk:reward ratio has a matching breakeven win rate hiding behind it. Here’s the maths that connects the two, a full reference table, and how to use it to judge whether a strategy’s numbers actually add up.